XML 36 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (unaudited) (USD $)
In Millions, unless otherwise specified
9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
OPERATING ACTIVITIES    
Net income $ 206.2 $ 207.0
Reconciliation to net cash provided by operating activities:    
Depreciation and amortization 91.8 88.9
Equity in earnings of unconsolidated affiliate (17.1) (13.8)
Dividends received from unconsolidated affiliate 2.8 6.3
Chapter 11 expenses, net of interest income 11.0 12.6
Chapter 11 expenses paid (11.2) (9.9)
Libby medical program settlement 0 19.6
Provision for income taxes 106.7 102.0
Income taxes paid, net of refunds (65.6) (41.6)
Interest accrued on pre-petition liabilities subject to compromise 28.1 30.0
Restructuring expenses and related asset impairments 8.7 6.4
Payments for restructuring expenses (3.8) (7.2)
Defined benefit pension expense 54.9 53.2
Payments under defined benefit pension arrangements (63.6) (122.5)
Provision for environmental remediation 4.0 1.8
Expenditures for environmental remediation (11.2) (8.1)
Changes in assets and liabilities, excluding effect of currency translation:    
Trade accounts receivable 5.2 (3.7)
Inventories (37.7) 20.6
Accounts payable 6.8 3.6
All other items, net (7.1) (10.2)
Net cash provided by (used for) operating activities 342.6 292.4
INVESTING ACTIVITIES    
Capital expenditures (117.9) (103.6)
Payments to Acquire Businesses, Net of Cash Acquired (15.8) (40.5)
Short-term Investments (500.0) 0
Transfer to restricted cash and cash equivalents 12.4 (24.1)
Proceeds from Divestiture of Businesses 1.8 0
Other investing activities 4.2 0.5
Net cash used for investing activities (615.3) (167.7)
FINANCING ACTIVITIES    
Net borrowings (repayments) under credit arrangements (3.0) 24.6
Proceeds from exercise of stock options 30.9 25.7
Other financing activities 6.1 5.1
Net cash (used for) provided by financing activities 0.3 78.4
Effect of currency exchange rate changes on cash and cash equivalents (9.8) (0.2)
Decrease in cash and cash equivalents (282.2) 202.9
Cash and cash equivalents, beginning of period 1,336.9 1,048.3
Cash and cash equivalents, end of period $ 1,054.7 $ 1,251.2